Table 2.
Loop | Mutant | Tropism | IC50 |
IC50 |
MPI |
---|---|---|---|---|---|
FC increase | |||||
Parental clone |
Wild type |
R5 |
1.47 nM |
- |
- |
V2 |
V169M |
R5 |
1.82 nM |
1.23 |
96% |
V3 |
L317W |
R5 |
2.24 nM |
1.52 |
95% |
V4 |
I408T |
R5 |
5.46 nM |
4.00 |
85% |
V2-V3 |
V169M |
R5 |
1.92 nM |
1.30 |
94.3% |
L317W | |||||
V2-V4 |
V169M |
R5 |
5.76 nM |
4.00 |
84% |
I408T | |||||
V3-V4 |
L317W |
R5 |
4.29 nM |
3.00 |
85% |
I408T | |||||
V2-V3-V4 |
V169M |
R5 | 4.88 nM | 3.31 | 83% |
L317W |
|||||
I408T |
IC50, 50% effective concentration or concentration needed to inhibit 50% of HIV. IC50 FC was calculated as the ratio IC50 for resistant virus/IC50 for wild type virus. MPI (maximum percent inhibition) was calculated as described in Methods.